Mick Radio-Nuclear Instruments, Inc., known internationally for its 40 years of service to the radiation therapy and brachytherapy communities, provides the highest-quality and state-of-the-art brachytherapy technology to confront the challenges faced in the fight against cancer. The company’s involvement in prostate and gynecological brachytherapy has resonated throughout the world. It remains today a strong and viable technology with proven excellent clinical outcomes at a reasonable cost. Mick Radio-Nuclear Instruments is committed to using its 40 years of manufacturing experience in the field of brachytherapy to best serve the special needs that we are often confronted with.
In 2013, European based Eckert & Ziegler BEBIG acquired Mick Radio-Nuclear Instruments, Inc. Eckert & Ziegler BEBIG is committed to the delivery of the highest quality, most efficient brachytherapy technologies and products that allow physicians worldwide to effectively treat patients diagnosed with cancer. Initially formed from a German science institute, Eckert & Ziegler BEBIG has a research and development heritage that continues to be evident today in the company’s ongoing commitment to advancing brachytherapy.